Epilepsy aggravated and Lymphoma

Summary:

Lymphoma is found among people with Epilepsy aggravated, especially for people who are male, 60+ old.

The study analyzes which people have Lymphoma with Epilepsy aggravated. It is created by eHealthMe based on reports of 31 people who have Epilepsy aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Epilepsy aggravated?

Epilepsy aggravated (serious common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,071 drugs and 456 conditions by eHealthMe. Check the latest studies of Epilepsy aggravated.

What is Lymphoma?

Lymphoma (cancer that begins in immune system cells) is found to be associated with 961 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Lymphoma.

On Jul, 14, 2026

31 people who have Epilepsy Aggravated and Lymphoma are studied.

Would you have Lymphoma when you have Epilepsy aggravated?

Gender of people who have Epilepsy Aggravated and experienced Lymphoma *:

female: 48.28 %
male: 51.72 %

Age of people who have Epilepsy Aggravated and experienced Lymphoma *:

Common co-existing conditions for these people *:

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 12.90%
Depression: 3 people, 9.68%
Stress And Anxiety: 2 people, 6.45%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 6.45%
Sinusitis (inflammation of sinus): 2 people, 6.45%
Neuralgia (pain in one or more nerves): 2 people, 6.45%
Migraine (headache): 2 people, 6.45%
High Blood Pressure: 2 people, 6.45%
Affective Disorder (mental disorder): 2 people, 6.45%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.23%

Common drugs taken by these people *:

Common symptoms for these people *:

Heavy Or Prolong Menstrual Bleeding: 3 people, 9.68%
Rash Erythematous (redness of the skin): 3 people, 9.68%
Rashes (redness): 3 people, 9.68%
Drowsiness: 2 people, 6.45%
Red Blood Cell Abnormality (abnormal red blood cells): 2 people, 6.45%
Laboratory Test Abnormal: 2 people, 6.45%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 6.45%
Nausea And Vomiting: 2 people, 6.45%
Dyspnea (difficult or laboured breathing): 2 people, 6.45%
Joint Pain: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lymphoma?

- Check whether Lymphoma is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .

Related studies:

Treatments, associated drugs and conditions:

Epilepsy aggravated (695 reports)
Lymphoma (33,395 reports)

All the drugs that are associated with Lymphoma:

Lymphoma (961 drugs)

All the conditions that are associated with Lymphoma:

Lymphoma (1,015 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lymphoma and Epilepsy aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.